1. Corporate Overview

2. Corporate Overview
 BIONITY is an independent consulting
firm focusing on complex project
assessment, valuation, financial
advisory, IPR consultancy, market
analysis and licensing.
Budapest
 We provide our services mainly to
biotech, pharma, medtech companies,
life sciences focused investors and
academic research institutions.
 Our office is located in Budapest,
Hungary, with a broad activity in Central
Eastern Europe.
|

3. Our Industry Focus:
Life Sciences
1.
 PreClinical / Clinical Stage Drug Development Projects
 Platform & Drug Delivery Technologies
2.
 Medical Device Developments
 Diagnostics & Analytical Technologies
3.
 CROs & SMOs
 BioInformatics
4.
 Development of API & Biological Manufacturing
Capacities
|

4. |

5. Pipeline Review and Valuations
Our expertise in financial valuation combined with our strategic partners -
specialized in legal, regulatory affairs & IPR - opens the door to a
comprehensive and sound review of pipelines.
 Scenario Analysis
 Value of each project scenario
 Value of pipeline
 Risk profile of pipeline
 Sales forecasts of each project (worst case, base case, best case)
 Defining key inflection points and value creation of projects.
|

6. Market Analysis
We support our clients with deep market assessment, and competitive
analysis to get a sound insight into . Market analysis can be combined
with competitor and product surveillance.
 SWOT and Five Forces Analysis
 Desk researches about competitive landscape and market potentials
 Primary Reseaches, Interviewing Key Opinion Leaders (KOLs)
 Analysis of the Probabilities of Success
 Analysis of potential market acceptance, Willingness to Prescribe
 Evaluation of Peak Sales dynamics, volatility, elasticity
|

7. FDI Promotion
Central and Eastern Europena life sciences sector is characterized with
highly skilled workforce, stable political and regulatory system & strong
governmental commitment. Whether it is a specialized R&D unit or a
large greenfield manufacturing plant, we help our clients to find the rigth
local partnes and ideal location.
 Market intelligence
 Feasibility studies on Foreign Direct Unvestments
 Academic, corporate match-making (R&D partners, subcontractors)
 Site Evaluation and Pre-selection services
 Negotiation with investment promotion agencies
 Supporting foreign companies to obtain permissions on fast-track
|

8. Strategic Financing
Our strong network with Life Sciences focused VCs , CVCs and HNWIs is
prerequested to reach and meet suitable investor(s) corresponding to the
financial needs, pipeline and stage of development.
 Reviewing the Teaser and Company Presentation
 Elaboration of Mid-term individual financial Strategies
 Defining and continously updateing the „Investors List
 Planning and organizing one-on-one meetings with potential investors
 Structuring the Term Sheet and assisting on the Due Diligence process
 Corporate restructuring and Corporate governance related to deals
|

9. Raising Capital
The discount rate for the valuation is elaborated for each company
individually based on our sound model that takes into account the
development stage of the pipeline projects, IP positions, indications,
stand-alone and market risks, operating costs and the business strategy
of the Company.
 CashFlow Analysis
 Profit and Loss Statement (P&L)
 Risk-Adjusted Net Present Value Calculations (rNPV)
 Real-Options Valutions (ROV)
 Deal-Sourcing and Pre-Selection Services for professional Investors
|

10. Licensing and Partnering
For a BioPharma company, securing IPR and exploiting such rights by
licensing/partnering constitute some of the most fundamental aspects of
the business. We help define which rights should be licensed and what
type of license should be granted.
 Developing Licensing Strategy
 License contract value for licensee and licensor (rNPV, Real Options)
 IRR for licensee and licensor
 Value share between licensor and licensee
 Identifying and contacting potential licensing partners
 Implementing, negotiating and managing License-In & Out deals
 Advising on Term Sheets and Licensing Agreements
|

11. Professional Background
Before founding Bionity R&D Investment Advisors in 2007, he was the director of the CEE
activities at PCA Capital Advisors (2005-2007), a Frankfurt based corporate finance boutique
focusing on biotechnology and ICT financing. Before he held the position of “Head of Priority
Sectors” at the Hungarian Investment and Trade Development Agency, ITDH (2002-2005). He is
fluent in English and French. He is the Board Member of the Hungarian Biotechnology
Association and member of the SME Platform of EuropaBio.
 Marcell Veidner He graduated in March 2011 at Biotech focused MBA program of IE Business School (Madrid,
Managing director Spain), a globally top ranked business school. He has been graduating at Budapest University
of Economic Science and Administration with major in entrepreneurship, and also obtained
+3620.284.9662 Master degree in “European Studies” at the same institution.
marcell.veidner@bionity.eu
|

12. Partnerships and Membership
Cogito Consuiting is an IPR and technology valuation specialist consulting firm
located in Budapest. Its expertise include novelty, patentability, FTO analysis
and strategic IPR consulting. Cogito is also supporting its clients with
evaluation of the market potential of new technologies.
www.cogitoconsuling.eu
The Hungarian Biotechnology Association (HBA) was established by Hungary's
leading human biotechnology companies with the aim of promoting the
development and representation of the Hungarian biotechnology sector.
www.hungariabiotech.org
|

13. marcell.veidner@bionity.eu
+36.20.284.9662
H-1036, Budapest
Perc u. 6.